Ochoa Soledad, Hernández-Lemus Enrique
Computational Genomics Division, National Institute of Genomic Medicine, Mexico City, Mexico.
Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Front Oncol. 2023 Jul 25;13:1148861. doi: 10.3389/fonc.2023.1148861. eCollection 2023.
Breast cancer is a complex disease that is influenced by the concurrent influence of multiple genetic and environmental factors. Recent advances in genomics and other high throughput biomolecular techniques (-omics) have provided numerous insights into the molecular mechanisms underlying breast cancer development and progression. A number of these mechanisms involve multiple layers of regulation. In this review, we summarize the current knowledge on the role of multiple omics in the regulation of breast cancer, including the effects of DNA methylation, non-coding RNA, and other epigenomic changes. We comment on how integrating such diverse mechanisms is envisioned as key to a more comprehensive understanding of breast carcinogenesis and cancer biology with relevance to prognostics, diagnostics and therapeutics. We also discuss the potential clinical implications of these findings and highlight areas for future research. Overall, our understanding of the molecular mechanisms of multi-omic regulation in breast cancer is rapidly increasing and has the potential to inform the development of novel therapeutic approaches for this disease.
乳腺癌是一种复杂的疾病,受到多种遗传和环境因素的共同影响。基因组学和其他高通量生物分子技术(“组学”)的最新进展为乳腺癌发生和发展的分子机制提供了诸多见解。其中许多机制涉及多层调控。在本综述中,我们总结了当前关于多种组学在乳腺癌调控中的作用的知识,包括DNA甲基化、非编码RNA和其他表观基因组变化的影响。我们评论了如何将这些多样的机制整合起来,这被视为更全面理解乳腺癌发生和癌症生物学(与预后、诊断和治疗相关)的关键。我们还讨论了这些发现的潜在临床意义,并突出了未来研究的领域。总体而言,我们对乳腺癌中多组学调控分子机制的理解正在迅速增加,并有潜力为这种疾病的新型治疗方法的开发提供信息。